Ilaris (canakinumab)

pCPA File Number: 21028
Negotiation Status:
Concluded with an LOI
Indication(s):
Systemic juvenile idiopathic arthritis
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: